Axogen, Inc. (AXGN)
NASDAQ: AXGN · Real-Time Price · USD
29.28
+0.73 (2.56%)
At close: Mar 9, 2026, 4:00 PM EDT
29.28
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:01 PM EDT
Axogen Revenue
In the year 2025, Axogen had annual revenue of $225.21M with 20.21% growth. Axogen had revenue of $59.90M in the quarter ending December 31, 2025, with 21.25% growth.
Revenue (ttm)
$225.21M
Revenue Growth
+20.21%
P/S Ratio
6.75
Revenue / Employee
$362,071
Employees
622
Market Cap
1.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 225.21M | 37.87M | 20.21% |
| Dec 31, 2024 | 187.34M | 28.33M | 17.81% |
| Dec 31, 2023 | 159.01M | 20.43M | 14.74% |
| Dec 31, 2022 | 138.58M | 11.23M | 8.81% |
| Dec 31, 2021 | 127.36M | 15.06M | 13.41% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| QuidelOrtho | 2.73B |
| Enovis | 2.25B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.01B |
| Inspire Medical Systems | 911.98M |
| NovoCure | 655.35M |
| UFP Technologies | 602.80M |
AXGN News
- 3 days ago - Axogen, Inc. (AXGN) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript - Seeking Alpha
- 12 days ago - Axogen Q4: EPS Miss Amid Biologics Transition - Seeking Alpha
- 13 days ago - Axogen, Inc. (AXGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 18 days ago - First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review - Seeking Alpha
- 20 days ago - Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences - GlobeNewsWire
- 27 days ago - Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 - GlobeNewsWire
- 4 weeks ago - Wasatch Micro Cap Fund Q4 2025 Performance Review - Seeking Alpha
- 6 weeks ago - Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock - GlobeNewsWire